C. Chu

发表

Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitis

C. Feeney, H. Valdez, M. Dibonaventura, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus

C. Sotozono, B. Kaffenberger, S. Rauz, 2023, Orphanet Journal of Rare Diseases.

Temporal shifts of the microbiome associated with antibiotic treatment of purpuric drug eruptions related to epidermal growth factor receptor inhibitors

K. L. Chen, C. Chu, P. Hsieh, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Drug reaction with eosinophilia and systemic symptoms with features resembling Stevens–Johnson syndrome/toxic epidermal necrolysis related to apalutamide

C. Chu, T. Hsieh, P. Huang, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.